ADMA
The not-so-dramatic annual report
ADMA’s latest annual report reads a lot like a company saying, “We’re fine, really.” The big takeaway: it ended 2025 with $88 million in cash, and it’s still returning capital to shareholders through repurchases.
The plasma center cleanup continues
There’s also a little spring cleaning in the background. Back in December 2025, ADMA agreed to sell three plasma collection centers for $12 million. By the time of the report, two had already closed, and the third was expected to finish in Q1 2026.
Why investors should care
This matters because plasma businesses live and die by supply, operating discipline, and balance-sheet flexibility. A company that can divest non-core assets, keep cash on hand, and still buy back stock is basically telling the market it thinks the engine is humming.
The report also noted 238,159,176 shares outstanding as of February 20, 2026, which gives you a sense of the scale of the company’s capital structure. Big picture: this isn’t flashy news, but it’s the kind of financial housekeeping that can quietly support a stock if execution stays intact.